News About: Pharm. Industry
Merck Korea to launch anti-diabetic drug "Glucophage XR"
Merck Korea, a subsidiary of German Merck, announced the market launching plan for an anti-diabetic drug called "Glucophage XR sustained tablet" in April, which was a sustained metformin tablet taking once 4 tablets (...
Fees for exclusive drug purchase credit card near at 1.5%.
As an alternative of modernizing the drug distribution system, the government raised an idea of establishing "Exclusive Drug Purchase Credit Card" system, which had been disputed over the rate of fees. However, the ra...
KPMA generated total 1511 medical representatives
The Korea Pharmaceutical Manufacturers Association (KPMA) announced through the web site (www.pharmaahub.co.kr) on March 24 that 83 trainees (75%) out of the total 111 candidates passed the 15th MR qualification exami...
Hanmi to reinforce investment for core projects.
Hanmi announced that the company would divest non-core business projects but intensify more for the pharmaceutical business as a core project.
Hanmi sold out wholly 900 thousand stocks of Youngnam Broadcast to CJ ...
Hanmi to appoint Mr. Lim Seon-min to new president for sales.Hanmi announced on March 28 that vice president Lim Seon-min promoted to new president in charge of all sales and marketing activities.
President Lim was bone in 1948 and gra...
|
Pfizer to launch Lyrica for neurotic pain and seizure therapy.Pfizer Korea launched Lyrica (pregabalin) for the treatment of neurotic pain and epileptic disease.
Lyrica (pregabalin) capsules is FDA-approved to treat painful diabetic per...
|
PPFK talked how to overcome low birth and high aged society.The Planned Population Federation of Korea (PPFK: head: Choi Seon-jeong) took "A brief broadcaster's meeting for the low birth and high aged society" at the 3rd floor of Mokdon...
|
4 awardees for the 44th Dong-Am prize finally determined
The 44th Dong-Am prizes, sponsored by Yakup Press, this year will be given to 5 winners including Prof. Choi Joon-shik (Chosun Univ. College of Pharmacy, 60 yr) in the academy area, Rep. Chang Bok-shim (National Assem...
Zuellig paid 2.6 billion won of royalty to head office last year.
Zuellig Pharma Korea reported the royalty payment to the head office, Zuellig Pharma Holdings. Ltd. at 2,640 million won on charge of the marketing and information services. (3,100 MW in 2004 and 2,635 MW in 2003). Zu...
Hanmi to construct new plant for Cephalosporin antibiotics.
Hanmi announced on March 23 that the board of director determined to construct a global standard of Cephalosporin antibiotic plant in conformance to the EU and cGMP standards at Pyongtaek by 32.4 billion won of invest...
